Modeling the complete kinetics of coxsackievirus B3 reveals human determinants of host-cell feedback
Open Access
- 1 April 2021
- journal article
- research article
- Published by Elsevier in Cell Systems
- Vol. 12 (4) , 304-323.e13
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Institutes of Health (T32-HL007284)
- University of Virginia (T32-HL007284)
- David and Lucile Packard Foundation (2009-34710)
This publication has 118 references indexed in Scilit:
- MAVS Forms Functional Prion-like Aggregates to Activate and Propagate Antiviral Innate Immune ResponseCell, 2011
- A public genome-scale lentiviral expression library of human ORFsNature Methods, 2011
- A diverse range of gene products are effectors of the type I interferon antiviral responseNature, 2011
- A loss‐of‐function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patientsEMBO Molecular Medicine, 2011
- Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursorProceedings of the National Academy of Sciences, 2007
- Two proton transfers in the transition state for nucleotidyl transfer catalyzed by RNA- and DNA-dependent RNA and DNA polymerasesProceedings of the National Academy of Sciences, 2007
- Viral protease cleavage of inhibitor of κBα triggers host cell apoptosisProceedings of the National Academy of Sciences, 2006
- The Specific and Essential Role of MAVS in Antiviral Innate Immune ResponsesImmunity, 2006
- Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virusNature, 2005
- Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3Cell, 2005